Slimming Pill category
Sibutramine Warning
Posted: Friday, 2 September, 2011 | Categories: reductil, diet pills, slimming pills
The Medicine and Healthcare Products Regulatory Agency (MHRA) warn that certain herbal slimming pills might contain sibutramine.
Sibutramine is associated with an increased risk of heart attack and stroke hence Reductil was removed from the market.
The regulatory body have warned those who have purchased herbal slimming aids and diet pills to consult their pharmacists before continuing to take these treatments.
Mango Seeds and Slimming Benefits
Posted: Wednesday, 3 August, 2011 | Categories: reductil, diet pills, slimming pills, slimming pills, weight loss, qnexa
One of the most popular products for slimming down at the moment is the African mango and there is proof of its success following two studies carried out in Cameroon. The seeds were extracted and the effects on weight loss and blood fat levels were assessed over a period of 4 weeks and compared to a placebo group.The results proved that the group lost on average 5.3% of their original body weight versus the placebo group who only lost 1.3%. Substantial decreases in blood cholesterol were observed in addition.
The seeds contain soluble fibre and delay the digestion process resulting in a slower passing of glucose into the blood stream. The ingredients of this herbal treatment however are contained in many herbal weight loss treatments that have not been tested by regulators. The product is therefore not recommended for consumption as of yet. Still Xenical is the only weight loss drug licensed for use in the EU.
We await news of the hopeful qnexa, Vivus’ promising weight loss treatment.
The Lancet Publishes on Qnexa's Latest News
Posted: Wednesday, 13 April, 2011 | Categories: reductil, diet pills, slimming pills, slimming pills, weight loss, qnexa, diet pills slimming pills
Vivus Inc’s CONQUER study revealed participants achieved 20 pounds weight loss on average during one year of taking a high dose of Qnexa, a substantial amount of weight loss when compared to other weight loss drug competitors at trial stage. This is the only appetite suppressant still in the running for approval this year and the success of the pharmaceutical company looks hopeful. The Lancet published safety and efficacy reports of the 56 week study which assessed patients suffering from high blood pressure, high cholesterol or type-2 diabetes across 93 states in the United States. Qnexa might yet prove to be the future in slimming pills yet.
Qnexa was successful in lowering blood pressure and cholesterol versus the placebo and will be evaluating its impact on type-2 diabetes and sleep apnea shortly. Approximately 2,500 obese men and women participated in the trial and where one group were to diet, exercise and receive counselling while taking Qnexa (a high dose or a low dose), the control group had to diet, exercise and receive counselling alone. After the 56 weeks, those taking the lower dose of Qnexa lost a significant 18 pounds. Those not taking Qnexa only lost 3 pounds. The group taking the weight loss drug also experienced a lowering of blood pressure, triglycerides, cholesterol levels and blood sugar levels.
Qnexa is a combination of phentermine, which is a weight loss drug in the US, and topiramate, which is traditionally used to treat migraine and epilepsy. Side effects included anxiety and depression and double the number of people dropped out of the study taking the high dose of the drug over those who received the counselling on its own.
Another problem the FDA (Food and Drug Administration) had with Qnexa last year related to its association with birth defects but none of the 34 women who became pregnant while participating in the study had babies born with defects. The application to the FDA will be submitted once again at the end of this year despite the positive news; it is still not clear from recent trials whether this weight loss drug could be suitable for long term use.
In the meantime, it is imperative to make sure that the diet pills or slimming pills one is taking are regulated by a reliable source.
Scottish Slimming Pill Bill
Posted: Thursday, 7 April, 2011 | Categories: reductil, diet pills, slimming pills, slimming pills, weight loss, qnexa, diet pills slimming pills, Diet Pill, slimming pill
Slimming pills are being slated by the Scots since reports revealed that there has been a 20% increase in the amount spent on such weight loss treatments over this last year. Now that the public will be receiving free prescriptions, it is suggested that the figures look set to rise again with estimates reading a whopping five million pounds of tax payer’s cash each year.
What doctors and patients must remember is that slimming pills and diet pills do not work without the patient maintaining a healthy diet and taking regular exercise. If this is enforced and regulated, perhaps the money spent on such treatment may actually serve to curb the problem of obesity in the UK.
With a quarter of the population of Scots obese, and with the consequent rates of obesity related illnesses on the rise, the only options are to be more vigilant and monitor the progress of those being treated.
Contrave Rejected
Posted: Tuesday, 8 February, 2011 | Categories: reductil, diet pills, slimming pills, slimming pills, weight loss, qnexa, diet pills slimming pills, Diet Pill, slimming pill, Slimming Pills
The Food and Drug Administration has paid no heed to the recommendations of its advisory panel for weight loss treatment, Contrave. This is blow for Orexigen Therapeutics, which was confident about the approval of the treatment based on the panel’s recommendations. The FDA usually goes with the recommendation of their panel but not on this occasion.
The FDA had fears over the use of Contrave in the long term and had suggested that a randomized, double blind trial be carried out on a large scale and for a sufficient length of time, in order to assess the risk of cardiovascular incidences.
Contrave is the third drug to be rejected over the year including Qnexa and Lorcaserin and furthermore, Reductil (Meridia) was taken off the market voluntarily by the pharmaceutical company in the United States late last year. It is both a daunting task to face the FDA during such a climate and an exciting one considering there is nothing on the market in the way of successful appetite suppressants. The market is there for the taking with right kind of drug.
Weight Loss Pills Lose Out
Posted: Wednesday, 10 November, 2010 | Categories: reductil, diet pills, slimming pills, slimming pills, weight loss, qnexa, diet pills slimming pills, Diet Pill, slimming pill, Slimming Pills
It’s been a bad few years, to say the least, for certain weight loss pills. Reductil and Acomplia, two weight-loss drugs, were both withdrawn from the market because of fears about possible side effects. It is no longer possible to obtain either.
Reductil was withdrawn at the beginning of 2010 after an extensive trial, which suggested that it increased the risk of non-fatal cardiovascular events.
Launched in 2006, Acomplia was also hailed as a wonder drug - forty per cent of those given the drug lost up to ten per cent of their body weight. Two years later, however, it was withdrawn from the market after research linked the drug to depression, psychosis and suicidal tendencies.
Both of these medications worked by changing the chemical processes which occurred in the brain when the patient ate food - it made them satisfied (full up) more quickly, which meant they ate less and in turn lost weight. Perhaps it’s not surprising that these drugs would have severe side effects when one considers the considerable effect that they had on the brain.
Xenical (Orlistat) is a weight loss medication that is, however, still available - either over the counter in a small dose as Alli or in a stronger dose on prescription. It works in a different way from either of the aforementioned drugs and causes the gut to get rid of excess fat in food. It is a successful and popular aid to in the battle many of us have to lose weight.
New Slimming Pill in the Pipeline
Posted: Wednesday, 7 October, 2009 | Categories: reductil, diet pills, slimming pills, slimming pills, weight loss, qnexa, diet pills slimming pills, Diet Pill, slimming pill, Slimming Pills, diet pill, slimming pill, Qnexa
Pharmaceutical experts and doctors are getting excited about promising new results released by the pharmaceutical firm Vivus into clinical trials of their new diet pill Qnexa.
The trials have indicated that the pill could be more effective than any pill currently on the market, with patients taking the high dose losing almost 15% of their body weight and those on the lower dose losing 8% of their body weight. The users of the diet pill also saw their blood pressure drop, the health of their heart improve and their chances of developing type 2 diabetes fall.
The pill combines two medications that have already been separately trialled. The first, phentermine, was a popular weight loss drug until 10 years ago when it fell out of favour with doctors due to safety concerns. The other is an epilepsy medication called Topiramate which has been shown to promote weight loss.
3,750 obese people took part in the trials and over the 53-week trial period the average amount lost was 14.7% of each patient’s body fat. The results have been described by the lead scientist on the trial, Dr Louis Aronne of the New York Presbytarian Hospital, as “spectacular.”
He went on to say that the results were as good as those experienced by patients who have had gastric bands fitted . He then added that those battling the obesity crisis were “in desperate need of more options and effective drugs to treat obesity and the results of this trial were extremely encouraging.”
Crackdown on Counterfeiting Criminals
Posted: Tuesday, 4 August, 2009 | Categories: reductil, diet pills, slimming pills, slimming pills, weight loss, qnexa, diet pills slimming pills, Diet Pill, slimming pill, Slimming Pills, diet pill, slimming pill, Qnexa, Counterfeit Medications
A upsurge in the activities of criminal gangs based in Britain has lead police chiefs to promise a crackdown, after fears were raised that they would push up the rate of illegal sales of counterfeit medications, particularly slimming pills
Law enforces plan to use “Al Capone” style tactics to get the country’s 30,000 organised criminals behind bars. They have said that if they can’t arrest them for drugs or people trafficking offences, then they will get them for tax evasion.
In a report released by the government, it became clear that the recession was only boosting their activities, particularly in the field of producing counterfeit goods. They warned that the slimming pill market was especially vulnerable to this, as well as other lifestyle medications like Viagra.
Counterfeiting medications, especially diet pills and erectile dysfunction medications, has become a very lucrative option for criminal gangs. However while the majority of criminal activity in this field was generally restricted to places like South East Asia, it has become apparent that home-grown crooks are seeking to get in on the action.
Home Secretary Alan Johnson said, “We are sending a clear message to these networks that we are doing everything in our power to stop them threatening our safety, damaging our communities and subverting our economy."